» Articles » PMID: 31259094

Antioxidant Activity, α-glucosidase Inhibition and Phytochemical Profiling of Leaf Extracts

Overview
Journal PeerJ
Date 2019 Jul 2
PMID 31259094
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes mellitus type II (DMT-2) is a widely spread metabolic disorder both in developed and developing countries. The role of oxidative stress is well established in DMT-2 pathogenesis. The synthetic drugs for DMT-2 are associated with serious side complications. Antioxidant and α-glucosidase inhibitory actions of phytochemicals from various plant species are considered as an alternative to synthetic drugs for DMT-2 management. The present study aimed to evaluate the antioxidant activity, α-glucosidase inhibitory potential and phytochemical profiling of .

Methods: The total phenolic and flavonoid contents, in vitro antioxidant activity (α, α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging and phosphomolybdenum method) and α-glucosidase inhibition of ultrasonicated hydroethanolic leaf extracts were determined spectrophotometrically. The results of DPPH assay and α-glucosidase inhibition were reported in terms of IC value. The phytochemical profiling was accomplished by UHPLC-Q-TOF/MS/MS technique.

Results And Discussion: Findings leaped 60% ethanolic extract as rich fraction regarding total phenolic and flavonoid contents. The 60% ethanolic fraction was a promising source of natural antioxidants and α-glucosidase inhibitory agents as indicated by anti-radical and enzyme inibitory activities. Kaempferol, rutin, hesperetin 5-O-glucoside, kaempferol-coumaroyl-glucoside, luteolin 3-glucoside, Isorhamnetin-3-O-rutinoside, trimethoxyflavone derivatives and citric acid were identified by UHPLC-Q-TOF-MS/MS. These compounds were believed to be responsible for the strong antioxidant and enzyme inhibitory activity of plant extracts. The extensive metabolite profiling of was carried out the first time as never reported previously. The might be an appropriate choice to manage diabetes mellitus in an alternate way. The findings may be further exploited extensively for toxicity evaluation to proceed with functional food development having antidiabetic attributes.

Citing Articles

Edible Pods Reveal Potential as an Anti-Diabetic Agent: UHPLC-QTOF-MS/MS-Based Chemical Profiling, In Silico, In Vitro, In Vivo, and Oxidative Stress Studies.

Sarkar A, Chakrabarti A, Bhaumik S, Debnath B, Singh S, Ghosh R Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065816 PMC: 11280426. DOI: 10.3390/ph17070968.


Antioxidant and Hypoglycemic Potential of Phytogenic Selenium Nanoparticle- and Light Regime-Mediated Callus Culture Extract.

Ali A, Mashwani Z, Raja N, Mohammad S, Ahmad M, Luna-Arias J ACS Omega. 2024; 9(18):20101-20118.

PMID: 38737082 PMC: 11079897. DOI: 10.1021/acsomega.3c10222.


Prospective Nutraceutical Effects of Cinnamon Derivatives Against Insulin Resistance in Type II Diabetes Mellitus-Evidence From the Literature.

Mohsin S, Saleem F, Humayun A, Tanweer A, Muddassir A Dose Response. 2023; 21(3):15593258231200527.

PMID: 37701673 PMC: 10494518. DOI: 10.1177/15593258231200527.


Comparison of Chemical Compositions and Antioxidant Activities for the Immature Fruits of Y.B. Chang and L.

Zhang Q, Song W, Tao G, Li Q, Wang L, Huang W Molecules. 2023; 28(13).

PMID: 37446717 PMC: 10343504. DOI: 10.3390/molecules28135057.


Metabolomics-Based Profiling via a Chemometric Approach to Investigate the Antidiabetic Property of Different Parts and Origins of L.

Sehaki C, Molinie R, Mathiron D, Fontaine J, Jullian N, Ayati F Metabolites. 2023; 13(2).

PMID: 36837894 PMC: 9960292. DOI: 10.3390/metabo13020275.


References
1.
Prieto P, Pineda M, Aguilar M . Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem. 1999; 269(2):337-41. DOI: 10.1006/abio.1999.4019. View

2.
Kim J, Kwon C, Son K . Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem. 2001; 64(11):2458-61. DOI: 10.1271/bbb.64.2458. View

3.
Pari L, Saravanan R . Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes. Chem Biol Interact. 2007; 169(1):15-24. DOI: 10.1016/j.cbi.2007.04.010. View

4.
van de Laar F . Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc Health Risk Manag. 2009; 4(6):1189-95. PMC: 2663450. DOI: 10.2147/vhrm.s3119. View

5.
Ceriello A, Testa R . Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care. 2009; 32 Suppl 2:S232-6. PMC: 2811469. DOI: 10.2337/dc09-S316. View